Letter by Ko et al Regarding Article, “Safety of Switching From a Vitamin K Antagonist to a Non–Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial”
- 9 July 2024
- journal article
- letter
- Published by Wolters Kluwer Health in Circulation
- Vol. 150 (2) , e25-e26
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled TrialCirculation, 2023
- A crosswalk of commonly used frailty scalesJournal of the American Geriatrics Society, 2023
- Emulation of Randomized Clinical Trials With Nonrandomized Database AnalysesJAMA, 2023
- Frailty and Clinical Outcomes of Direct Oral Anticoagulants Versus Warfarin in Older Adults With Atrial FibrillationAnnals of Internal Medicine, 2021